The group’s principle activity is to distribute critical care products including plasma derivatives, albumin, immune globulins, coagulation factors and hyperimmunes. The group’s product line includes sensitive therapeutics in medicine used to treat trauma, autoimmune conditions, immune deficiencies, infectious diseases, bleeding disorders, and other life-threatening conditions. The group operates from United States.
